Source: ERS webinar 2021: Challenges in the management of SCLC



Rating:

Share or cite this content

Citations should be made in the following way:
T. Blum (Berlin, Germany), J. Cadranel (Paris, France), D. Jovanovic (Belgrade, Serbia). Challenges in the management of SCLC. ERS webinar 2021: Challenges in the management of SCLC

Member's Comments

No comment yet.

Related content which might interest you: Lung cancer Source: Respipedia Article Year: 2018 Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 European treatment guidelines: small cell lung cancer (SCLC) Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Management of extensive disease-small cell lung cancer Source: Eur Respir Mon; 2009: 44: 310–317 Year: 2009 Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 The effect of surgical specimen-derived phosphorus and lead concentrations in non-small cell lung cancer patients on disease course Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Surgical treatmment non-small cell lung cancer in the elderly patients Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Multiple primary malignancies in Japanese patients with non-small cell lung cancer Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Lung cancer: does age affect treatment strategy? Source: Eur Respir Mon; 2009: 43:306–326 Year: 2009 Small cell lung cancer in patients with elderly Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007 Chemotherapy for small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006 Treatment of extensive-stage small cell lung carcinoma: current status and future prospects Source: Eur Respir J 2010; 35: 202-215 Year: 2010 The role of palliative radiotherapy in locally advanced non small cell lung cancer Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007 Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Radiotherapy of nonsmall and small cell lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=190 Year: 2001